semaglutide drug shortage The Wegovy Continues, Leaving Patients On the Weight Loss in Limbo fda announcement semaglutide As of

Across all three compounds, the most commonly reported adverse events are nausea (typically mild to moderate, most pronounced during dose escalation phases, and improving with continued administration), vomiting, diarrhea, decreased appetite, and constipation

Key players include Novo Nordisk, Eli Lilly and Company, Pfizer, Amgen, AstraZeneca, Boehringer Ingelheim, Sanofi, Regeneron, Viking Therapeutics, Inc., and Terns Pharmaceuticals - competing across injectable, oral, and next-gen incretin-based therapies

Mitochondria contribute to nadph generation in mouse rod photoreceptors

High-protein meals help preserve muscle and support steady weight loss while on semaglutide.

Study Used AI to Analyze Real-World Patient Reports To better understand how people experience GLP-1 drugs outside of clinical trials, researchers used AI to analyze Reddit posts from 2019 to 2025

UK regulatory guidance (MHRA, SmPC) explicitly states Ozempic should be avoided during lactation as it is unknown whether semaglutide is excreted in human breast milk